Gene expression profiles of NO- and HNO-donor treated breast cancer cells: Insights into tumor response and resistance pathways

Robert Y.S. Cheng, Debashree Basudhar, Lisa A. Ridnour, Julie L. Heinecke, Aparna H. Kesarwala, Sharon Glynn, Christopher H. Switzer, Stefan Ambs, Katrina M. Miranda, David A. Wink

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Nitric oxide (NO) synthase 2 (NOS2), a major inflammatory protein, modulates disease progression via NO in a number of pathologies, including cancer. The role of NOS2-derived NO is not only flux-dependent, which is higher in mouse vs human cells, but also varies based on spatial and temporal distribution both within tumor cells and in the tumor microenvironment. NO donors have been utilized to mimic NO flux conditions and to investigate the effects of varied NO concentrations. As a wide range of effects mediated by NO and other nitrogen oxides such as nitroxyl (HNO) have been elucidated, multiple NO- and HNO-releasing compounds have been developed as potential therapeutics, including as tumor modulators. One of the challenges is to determine differences in biomarker expression from extracellular vs intracellular generation of NO or HNO. Taking advantage of new NO and HNO releasing agents, we have characterized the gene expression profile of estrogen receptor-negative human breast cancer (MDA-MB-231) cells following exposure to aspirin, the NO donor DEA/NO, the HNO donor IPA/NO andtheir intracellularly-activated prodrug conjugates DEA/NO-aspirin and IPA/NO-aspirin. Comparison of the gene expression profiles demonstrated that several genes were uniquely expressed with respect to NO or HNO, such as miR-21, HSP70, cystathionine γ-lyase and IL24. These findings provide insight into targets and pathways that could be therapeutically exploited by the redox related species NO and HNO.

Original languageEnglish (US)
Pages (from-to)17-28
Number of pages12
JournalNitric Oxide - Biology and Chemistry
StatePublished - Dec 1 2014


  • Breast cancer
  • Cancer biology
  • Cell signaling
  • Nitric oxide
  • Nitric oxide synthase
  • Nitroxyl

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Clinical Biochemistry
  • Cancer Research


Dive into the research topics of 'Gene expression profiles of NO- and HNO-donor treated breast cancer cells: Insights into tumor response and resistance pathways'. Together they form a unique fingerprint.

Cite this